Skip to main content

Month: June 2020

Vaisala Corporation: Managers’ Transactions – Voipio, Raimo

Vaisala CorporationManagers’ TransactionsJune 10, 2020 at 1:00 p.m. (EEST)Person subject to the notification requirementName: Voipio, RaimoPosition: Member of the Board/Deputy memberIssuer: Vaisala OyjLEI: 743700RNDD7KU11HW873Notification type: INITIAL NOTIFICATIONReference number: 743700RNDD7KU11HW873_20200610101531_11____________________________________________Transaction date: 2020-06-08Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009900682Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATIONTransaction details(1): Volume: 522 Unit price: NaN N/AAggregated transactions(1): Volume: 522 Volume weighted average price: N/AMore information Kaarina Muurinen, CFOTel. +358 40 577 5066Vaisala Corporation

Continue reading

Vaisala Oyj: Johtohenkilöiden liiketoimet – Voipio, Raimo

Vaisala OyjJohtohenkilöiden liiketoimet10.6.2020 klo 13.00IlmoitusvelvollinenNimi: Voipio, RaimoAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Vaisala OyjLEI: 743700RNDD7KU11HW873Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700RNDD7KU11HW873_20200610101531_11____________________________________________Liiketoimen päivämäärä: 2020-06-08Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009900682Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINENLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 522 Yksikköhinta: NaN N/ALiiketoimien yhdistetyt tiedot(1): Volyymi: 522 Keskihinta: N/ALisätietoja Kaarina Muurinen, talousjohtajaPuh. 040 577 5066Vaisala Oyj

Continue reading

New Data Indicates COVID-19 Financial Impact on Canadians Turning a Corner

TORONTO, June 10, 2020 (GLOBE NEWSWIRE) — TransUnion’s latest weekly study looking at the impact of COVID-19 on consumer finances in Canada, reveals consumers’ shifting mindset from panic to preparedness. The survey of 1,078 adults conducted on the week commencing June 1, 2020, reveals that consumers are adjusting to a new normal around their budgeting, and that government support and bank forbearance programs continue to provide financial relief.Consumer mindset shifting from panic to preparednessThe proportion of consumers saying they are negatively affected by COVID-19 has dropped to 55.1% (down from 58% the week prior and 57% in Week #1 over two months ago) representing the lowest rate since the survey started at the end of March. The percentage of Canadians who expect their household income to be negatively impacted is also...

Continue reading

Check Point Software Launches CloudGuard Cloud Native Security, Delivering Complete Protection for Any Cloud and Workload

SAN CARLOS, Calif., June 10, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cyber security solutions globally, has introduced CloudGuard Cloud Native Security, a fully-automated cloud platform that enables customers to seamlessly protect all of their cloud deployments and workloads, and manage security through a single pane of glass.  CloudGuard streamlines and simplifies cloud security, preventing the most advanced 6th generation cyber-attacks from impacting organizations’ cloud environments, and enables them to take full advantage of the speed and agility of cloud.Rapid migration to the cloud is the biggest cause of breakages in enterprise security architectures, according to the SANS 2020 Cybersecurity Spending Survey, with over half of respondents citing increased use of...

Continue reading

Liberty Gold Increases Strategic Land Holding at the Black Pine Oxide Gold Project in Idaho

VANCOUVER, British Columbia, June 10, 2020 (GLOBE NEWSWIRE) — Liberty Gold Corp. (LGD-TSX) (“Liberty Gold” or the “Company”) is pleased to announce as part of its regional exploration and compilation program, the staking of two additional land parcels, adding to the core Black Pine Project claim block, as well as an area 7 kilometres (“km”) to the west of the main oxide gold discovery area. The parcels aggregate 122 new claims.Liberty Gold staked:2.9 square km (“km2”) on the northwest corner of the core claim block to cover an extension of the Back Range portion of the Black Pine oxide gold system, where rock samples report up to 2 grams per tonne gold (“g/t Au”).3.4 km2 of ground to the north of the core claim block to cover iron oxide-stained and brecciated sandstone cover rocks, which typically lie above the favourable oxide...

Continue reading

Vaisala Corporation: Managers’ Transactions – Voipio, Ville

Vaisala CorporationManagers’ TransactionsJune 10, 2020 at 1:00 p.m. (EEST)Person subject to the notification requirementName: Voipio, VillePosition: Member of the Board/Deputy memberIssuer: Vaisala OyjLEI: 743700RNDD7KU11HW873Notification type: INITIAL NOTIFICATIONReference number: 743700RNDD7KU11HW873_20200610100218_9____________________________________________Transaction date: 2020-06-08Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009900682Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATIONTransaction details(1): Volume: 406 Unit price: NaN N/AAggregated transactions(1): Volume: 406 Volume weighted average price: N/AMore information Kaarina Muurinen, CFOTel. +358 40 577 5066Vaisala Corporation

Continue reading

Vaisala Oyj: Johtohenkilöiden liiketoimet – Voipio, Ville

Vaisala OyjJohtohenkilöiden liiketoimet10.6.2020 klo 13.00IlmoitusvelvollinenNimi: Voipio, VilleAsema: Hallituksen jäsen/varajäsenLiikkeeseenlaskija: Vaisala OyjLEI: 743700RNDD7KU11HW873Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700RNDD7KU11HW873_20200610100218_9____________________________________________Liiketoimen päivämäärä: 2020-06-08Kauppapaikka: NASDAQ HELSINKI LTD (XHEL)Instrumenttityyppi: OSAKEISIN: FI0009900682Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINENLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 406 Yksikköhinta: NaN N/ALiiketoimien yhdistetyt tiedot(1): Volyymi: 406 Keskihinta: N/ALisätietoja Kaarina Muurinen, talousjohtajaPuh. 040 577 5066Vaisala Oyj

Continue reading

Axovant Announces Year-End Financial Results and Expected Key Clinical Milestones in Q4 2020

Completed enrollment of cohort 2 of SUNRISE-PD Phase 2 study of AXO-Lenti-PD in Parkinson’s disease, with data from this cohort expected in Q4 2020Completed enrollment of low-dose cohort of Phase 1/2 clinical study of AXO-AAV-GM1 for GM1 gangliosidosis, with data from this cohort expected in Q4 2020Cash position of $80.8 million as of March 31, 2020 and expected runway into the second calendar quarter of 2021NEW YORK and BASEL, Switzerland, June 10, 2020 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today provided financial results and corporate updates for its fiscal year ended March 31, 2020.“Over the last year, Axovant has progressed toward becoming a leading gene therapy company focused on delivering transformative benefit...

Continue reading

RADA Announces $25 Million in New Orders During April and May 2020

NETANYA, Israel, June 10, 2020 (GLOBE NEWSWIRE) — RADA Electronic Industries Ltd. (NASDAQ: RADA) announced the receipt of over $25 million in new orders during the months of April and May 2020, a record for a two month time period.The aggregate amount of new orders since the beginning of 2020 reached $41 million, more than double when compared to the $19 million received during the same period in 2019.Out of the $25 million in new orders, the vast majority were orders for RADA’s software-defined tactical radars for counter UAV, short-range air defense (SHORAD) and counter fires (C-RAM). The majority were orders from new defense customers. These customers have placed significant initial orders with RADA and represent substantial follow-on potential. All these new orders are expected to be delivered during 2020.Dov Sella, RADA’s CEO,...

Continue reading

Genmab and AbbVie Announce Broad Oncology Collaboration

Company AnnouncementGenmab and AbbVie entered into a broad collaboration to jointly develop and commercialize three of Genmab’s next-generation bispecific antibody products, including epcoritamabCompanies establish a discovery research collaboration to create additional differentiated antibody therapeutics for cancerAbbVie to pay Genmab an upfront payment of USD 750 million with total potential milestone payments of up to USD 3.15 billionCopenhagen, Denmark and North Chicago, Illinois; June 10, 2020 – Genmab A/S (Nasdaq: GMAB) and AbbVie Inc. (NYSE: ABBV) announced today that Genmab and AbbVie have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab’s early-stage investigational bispecific antibody product candidates and enter into a discovery research collaboration for future differentiated antibody...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.